Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer

Cancer

Volumn 116, Issue 24, 2010, Pages 5676-5685

  Donnem, Tom ^a,b   Andersen, Sigve ^a,b   Al Shibli, Khalid ^a,c   Al Saad, Samer ^a,b   Busund, Lill Tove ^a,b   Bremnes, Roy M ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c NORDLAND HOSPITAL   (Norway)

Author keywords

angiogenesis; Delta like ligand 4; Jagged 1; nonsmall cell lung cancer; Notch

Indexed keywords

BIOLOGICAL MARKER; DELTA LIKE LIGAND 4; JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH4 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADENOCARCINOMA; AGED; CALCIUM-BINDING PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650082224     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25551     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ,. Cancer statistics 2007. CA Cancer J Clin. 2007; 57: 43-66.
2. Curran WJ Jr,. Treatment of locally advanced nonsmall cell lung cancer: what we have and have not learned over the past decade. Semin Oncol. 2005; 32: S2-S5.
3. Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L,. Rational targeting of Notch signaling in cancer. Oncogene. 2008; 27: 5124-5131.
4. Kerbel RS,. Tumor angiogenesis. N Engl J Med. 2008; 358: 2039-2049.
5. Li JL, Harris AL,. Crosstalk of VEGF and Notch pathways in tumor angiogenesis: therapeutic implications. Front Biosci. 2009; 14: 3094-3110.
6. Li JL, Harris AL,. Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell. 2005; 8: 1-3.
7. Chen Y, De Marco MA, Graziani I, et al. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res. 2007; 67: 7954-7959.
8. Williams CK, Li JL, Murga M, Harris AL, Tosato G,. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood. 2006; 107: 931-939.
9. Jundt F, Anagnostopoulos I, Muehlinghaus G, et al. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002; 99: 3398-3403.
10. Houde C, Li Y, Song L, et al. Over-expression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood. 2004; 104: 3697-3704.
11. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for nonsmall-cell lung cancer. N Engl J Med. 2006; 355: 2542-2550.
12. Scagliotti G, Hanna N, Fossella F, et al. The differential efficacy of pemetrexed according to NSCLC histology: a review of 2 phase III studies. Oncologist. 2009; 14: 253-263.
13. Donnem T, Al Saad S, Al Shibli K, et al. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res. 2007; 13: 6649-6657.
14. World Health Organization. Histological Typing of Lung and Pleural Tumors. 3rd ed. Geneva, Switzerland: Springer-Verlag; 1999.
15. Reedijk M, Odorcic S, Chang L, et al. High-level coexpression of JAG1 and NOTCH-1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005; 65: 8530-8537.
16. Yeh TS, Wu CW, Hsu KW, et al. The activated Notch-1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res. 2009; 69: 5039-5048.
17. Reedijk M, Odorcic S, Zhang H, et al. Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol. 2008; 33: 1223-1229.
18. Shi TP, Xu H, Wei JF, et al. Association of low expression of notch-1 and jagged-1 in human papillary bladder cancer and shorter survival. J Urol. 2008; 180: 361-366.
19. Lee SM, Jun CK, Ko HY, et al. Expression of Notch 1 and 3 is related to inhibition of lymph node metastasis and progression in nonsmall cell lung carcinomas. Basic Appl Pathol. 2008; 1: 93-97.
20. Westhoff B, Colaluca IN, D'Ario G, et al. Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci U S A. 2009; 106: 22293-22298.
21. Zheng Q, Qin H, Zhang H, et al. Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549. Oncol Rep. 2007; 17: 847-852.
22. Sriuranpong V, Borges MW, Ravi RK, et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001; 61: 3200-3205.
23. Chen DL, Dehdashti F,. Advances in positron emission tomographic imaging of lung cancer. Proc Am Thorac Soc. 2005; 2: 541-544.
24. Martinez JC, Muller MM, Turley H, et al. Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues. Histopathology. 2009; 54: 598-606.
25. Li JL, Sainson RC, Shi W, et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res. 2007; 67: 11244-11253.
26. Thurston G, Kitajewski J,. VEGF and Delta-Notch: interacting signaling pathways in tumor angiogenesis. Br J Cancer. 2008; 99: 1204-1209.
27. Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL,. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 2005; 65: 8690-8697.
28. Noguera-Troise I, Daly C, Papadopoulos NJ, et al. Blockade of Dll4 inhibits tumor growth by promoting nonproductive angiogenesis. Nature. 2006; 444: 1032-1037.
29. Ridgway J, Zhang G, Wu Y, et al. Inhibition of Dll4 signaling inhibits tumor growth by deregulating angiogenesis. Nature. 2006; 444: 1083-1087.